Paper36909147
Reduced Electroretinogram Responses in Morphologically Normal Retina in Patients with Primary Hyperoxaluria Type 1.
Naaman E and 8 others. Ophthalmol Sci, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Reduced Electroretinogram Responses in Morphologically Normal Retina in Patients with Primary Hyperoxaluria Type 1. Papers, record 36909147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36909147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reduced Electroretinogram Responses in Morphologically Normal Retina in Patients with Primary Hyperoxaluria Type 1.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29244539 | Genotype-phenotype variability of retinal manifestation in primary hyperoxaluria type 1. | Ophthalmic Genet | 2018 | https://conductscience.org/library/papers/29244539 | PubMed |
| 2 | 17224183 | Evaluation of intravitreal kenalog toxicity in humans. | Ophthalmology | 2007 | https://conductscience.org/library/papers/17224183 | PubMed |
| 3 | 23944302 | Primary hyperoxaluria. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23944302 | PubMed |
| 4 | 10765968 | Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. | Doc Ophthalmol | 1998 | https://conductscience.org/library/papers/10765968 | PubMed |
| 5 | 6704017 | Ocular involvement in primary hyperoxaluria. | Arch Ophthalmol | 1984 | https://conductscience.org/library/papers/6704017 | PubMed |
| 6 | 31895888 | Future treatments for hyperoxaluria. | Curr Opin Urol | 2020 | https://conductscience.org/library/papers/31895888 | PubMed |
| 7 | 1739695 | A clinicopathological study of ocular involvement in primary hyperoxaluria type I. | Br J Ophthalmol | 1992 | https://conductscience.org/library/papers/1739695 | PubMed |
| 8 | 2003800 | Ocular histopathologic findings in a 46-year-old man with primary hyperoxaluria. | Arch Ophthalmol | 1991 | https://conductscience.org/library/papers/2003800 | PubMed |
| 9 | 35212129 | Electronegative electroretinogram in the modern multimodal imaging era. | Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/35212129 | PubMed |
| 10 | 15580002 | Retinal oxalosis in primary hyperoxaluria type 1. | Retina | 2004 | https://conductscience.org/library/papers/15580002 | PubMed |
| 11 | 7426550 | Ophthalmic manifestations of primary oxalosis. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7426550 | PubMed |
| 12 | 27135212 | DETAILED CLINICAL PHENOTYPING OF OXALATE MACULOPATHY IN PRIMARY HYPEROXALURIA TYPE 1 AND REVIEW OF THE LITERATURE. | Retina | 2016 | https://conductscience.org/library/papers/27135212 | PubMed |
| 13 | 2297338 | Ocular findings in primary hyperoxaluria. | Arch Ophthalmol | 1990 | https://conductscience.org/library/papers/2297338 | PubMed |
| 14 | 34127841 | Negative electroretinograms: genetic and acquired causes, diagnostic approaches and physiological insights. | Eye (Lond) | 2021 | https://conductscience.org/library/papers/34127841 | PubMed |
| 15 | 31078535 | The Ocular Phenotype in Primary Hyperoxaluria Type 1. | Am J Ophthalmol | 2019 | https://conductscience.org/library/papers/31078535 | PubMed |
| 16 | 34022071 | Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria. | Br J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/34022071 | PubMed |
| 17 | 36703385 | Induction of retinopathy by fibrillar oxalate assemblies. | Commun Chem | 2020 | https://conductscience.org/library/papers/36703385 | PubMed |
| 18 | 22688746 | An update on primary hyperoxaluria. | Nat Rev Nephrol | 2012 | https://conductscience.org/library/papers/22688746 | PubMed |
| 19 | 25502644 | ISCEV Standard for full-field clinical electroretinography (2015 update). | Doc Ophthalmol | 2015 | https://conductscience.org/library/papers/25502644 | PubMed |
| 20 | 12095827 | Choroidal neovascularization in primary hyperoxaluria. | Am J Ophthalmol | 2002 | https://conductscience.org/library/papers/12095827 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39311781 | Infant primary hyperoxaluria type 1: A case report and literature review. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/39311781 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AGXT | 189 | PubTator's text mining | https://conductscience.org/library/genes/189 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36909147
GET https://conductscience.org/api/papers/v1/36909147/references?page=2